Needham Upgrades Penumbra (PEN) to Buy Amid 2026 Growth Outlook
Penumbra, Inc. (NYSE:PEN) ranks among the best medical device stocks to invest in. Needham raised Penumbra, Inc.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | AQR Capital Management Cliff Asness | 330,990 | $84,938,599 | +140% | 0.07% |
2. | Citadel Investment Group Ken Griffin | 218,992 | $56,199,917 | -73% | 0.01% |
3. | GLG Partners Noam Gottesman | 206,461 | $52,984,087 | +1863% | 0.1% |
4. | Partner Fund Management Christopher Medlock James | 166,261 | $42,667,560 | 3.63% | |
5. | Point72 Asset Management Steve Cohen | 140,045 | $35,939,689 | -15% | 0.07% |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$156.40 | 700 | $109,480.00 | 3,850 | 2018-05-25 | Filing | |
$25.50 | 1,538 | $39,219.00 | 2,538 | 2016-05-19 | Filing |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$248.61 | 186 | $46,241.46 | 8,702 | 2025-10-02 | Filing | |
$256.63 | 5 | $1,283.15 | 64,257 | 2025-10-01 | Filing | |
$254.96 | 36 | $9,178.56 | 64,262 | 2025-10-01 | Filing | |
$254.05 | 20 | $5,081.00 | 64,298 | 2025-10-01 | Filing | |
$252.36 | 41 | $10,346.76 | 64,318 | 2025-10-01 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 429,172 | $108,717,851 | 0.72% | |
2. | 148,271 | $37,560,009 | 0.04% | |
3. | 19,812 | $5,018,776 | 0.12% | |
4. | 12,670 | $3,209,564 | 0.03% | |
5. | 6,625 | $1,678,245 | 0.01% |